Loading
Loading…
Loading…
| # | Company | Offered Item | Amount | Rank | Status |
|---|---|---|---|---|---|
| 1 | L1₹22.5 LQualified Make: Toujeo Solostar 450IU pen
Model: Toujeo Solostar 450IU Pen
Title: Human Insulin Analogue Glargin(Recombinant DNA origin) 450 IU/1.5ml PFS Disposable pen with 5 needl CTS NO 117 B SANOFI HOUSE SAKI VIHAR ROAD L AND T BUSINESS PARK POWAI MUMBAI MAHARASHTRA 400072 | MUMBAI SUBURBAN | MAHARASHTRA | 400072 | Make: Toujeo Solostar 450IU pen
Model: Toujeo Solostar 450IU Pen
Title: Human Insulin Analogue Glargin(Recombinant DNA origin) 450 IU/1.5ml PFS Disposable pen with 5 needl | ₹22.5 L | L1 | Qualified MII |
Tender Value
Refer Docs
EMD Value
₹11,261
Closing Date
23 Aug 2024, 12:00 pmClosed
Inj Human insulin analogue Glargine (Recombinant DNA orgin) 450 IU/1.5 ml PFS Disposable Pen with 5
6581931
GEM/2024/B/5107239
Two Packet Bid
Inj Human insulin analogue Glargine (Recombinant DNA orgin) 450 IU/1.5 ml PFS Disposable Pen with 5
15 days
Maharashtra; Pune
Total value wise evaluation
PRODUCT_CUSTOM
7 documents required · 7 mandatory
3 yrs
₹3
60%
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| Inj Human insulin analogue Glargine (Recombinant DNA orgin) 450 IU/1.5 ml PFS Disposable Pen with 5 | PUNE | 1,500 | 15 days |
₹11,261
23 Aug 2024
2 Aug 2024
23 Aug 2024
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_6581931.pdf
GEM_BID
re_68_spec_2024-06-27-18-59-25_fa544c1da425b5c83bc9fe2e3f7de269.pdf
SPECIFICATION
world-bank-stc_1704778647.pdf
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .